Real-World Users of Triple Therapy for Asthma in the US
The American Journal of Managed Care · 2024
DOI: 10.37765/ajmc.2024.89494 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Managed Care, 2024. Verfasst von Nadia N Hansel und 7 weiteren Autor:innen. Beteiligte Einrichtung: GSK, 5 Moore Dr, Research Triangle Park, NC 27709. Email: cmaverell@gmail.com. Hauptthemen laut MEDLINE: Asthma, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- GSK, 5 Moore Dr, Research Triangle Park, NC 27709. Email: cmaverell@gmail.com.
Zitieren
APA
Hansel, N. N., Abbott, C. B., Averell, C. M., Germain, G., Laliberté, F., Mahendran, M., Duh, M. S., & Settipane, R. A. (2024). Real-World Users of Triple Therapy for Asthma in the US. The American Journal of Managed Care. https://doi.org/10.37765/ajmc.2024.89494
Vancouver
Hansel NN, Abbott CB, Averell CM, Germain G, Laliberté F, Mahendran M, et al. Real-World Users of Triple Therapy for Asthma in the US. The American Journal of Managed Care. 2024. doi:10.37765/ajmc.2024.89494
BibTeX
@article{Hansel2024,
author = {Hansel, Nadia N and Abbott, Carl B and Averell, Carlyne M and Germain, Guillaume and Laliberté, François and Mahendran, Malena and Duh, Mei S and Settipane, Russell A},
title = {Real-World Users of Triple Therapy for Asthma in the US},
journal = {The American Journal of Managed Care},
year = {2024},
doi = {10.37765/ajmc.2024.89494}
}
EUVIMED